REQUEST A DEMO
Total
USD $0.00
Search more companies

Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Sunshine Guojian Pharmaceutical (Shanghai)Co.,Ltd. is focused on the R&D of antibody drugs. The company provides tumor necrosis factor inhibitor and recombinant anti-CD25 humanized monoclonal antibody injection. The company was founded in 2002, headquartered in Shanghai City, China.

Headquarters
399 Li Bing Road, China (Shanghai) Free Trade Pilot Zone
Shanghai; Shanghai; Postal Code: 201203

Contact Details: Purchase the Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. report to view the information.

Website: http://www.3s-guojian.com

Basic Information
Total Employees:
Purchase the Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. report to view the information.
Registered Capital:
Purchase the Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. report to view the information.
Incorporation Date:
January 25, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
35.92%
Purchase this report to view the information.
34.48%
Purchase this report to view the information.
6.42%
Purchase this report to view the information.
4.08%
Purchase this report to view the information.
1.78%
Subsidiaries
Dansheng Medical Technology (Shanghai) Co., Ltd.
100%
Sansheng Guojian Pharmaceutical (Suzhou) Co., Ltd.
100%
Shanghai Shengguo Pharmaceutical Development Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
28.72%
Total operating revenue
28.98%
Operating profit (EBIT)
215.32%
EBITDA
200.42%
Net Profit (Loss) for the Period
190.2%
Total assets
8.84%
Total equity
7.36%
Operating Profit Margin (ROS)
23.03%
Net Profit Margin
18.51%
Return on Equity (ROE)
1.13%
Debt to Equity Ratio
-0.07%
Quick Ratio
-6.28%
Cash Ratio
-5.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?